MedSun: SightNet
SightNet
These subnetworks are designed to collect and share information about actual and potential adverse events from specific clinical areas of MedSun facilities using high-risk products.
For related information, see the latest device approvals that may be relevant to your specific clinical area.
The following is the latest content from the SightNet Subnetwork:
SightNet
Focuses on adverse events observed with ophthalmic medical devices used in providing all levels of eye care. To see recently submitted MedSun Opthalamic Device Reports, see Ophthalmic Devices.
FDA Letter to Eye Care Professionals |
Print Item E–mail Item |
FDA website
FDA has received information, comments, and complaints from interested persons regarding the promotion and advertising of LASIK procedures and the FDA-approved lasers used in LASIK procedures. The FDA believes that eliminating deceptive or misleading health-related advertising claims is an important part of protecting the public health. The FDA LASIK website can also be used as a resource for eye care professionals.
Additional Information:
FDA Letter to Eye Care Professionals. FDA LASIK website. May 22, 2009.
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/LASIK/ucm154882.htm
Latest on FDA's LASIK Program. FDA LASIK website. May 22, 2009.
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/LASIK/ucm061421.htm
All SightNet Content to Date
- (July 2009) FDA Letter to Eye Care Professionals
- (November 2008) Still Not Seeing Clearly - A Second Look at Intraocular Lens Implant Events
Updated November 23, 2009